{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Antinociceptive", "Isopulegol", "Monoterpene"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "30053451", "DateCompleted": {"Year": "2018", "Month": "09", "Day": "18"}, "DateRevised": {"Year": "2019", "Month": "12", "Day": "10"}, "Article": {"ArticleDate": [{"Year": "2018", "Month": "07", "Day": "24"}], "Language": ["eng"], "ELocationID": ["10.1016/j.cbi.2018.07.019", "S0009-2797(18)30352-1"], "Journal": {"ISSN": "1872-7786", "JournalIssue": {"Volume": "293", "PubDate": {"Year": "2018", "Month": "Sep", "Day": "25"}}, "Title": "Chemico-biological interactions", "ISOAbbreviation": "Chem Biol Interact"}, "ArticleTitle": "Effects of isopulegol in acute nociception in mice: Possible involvement of muscarinic receptors, opioid system and l-arginine/NO/cGMP pathway.", "Pagination": {"StartPage": "55", "EndPage": "60", "MedlinePgn": "55-60"}, "Abstract": {"AbstractText": ["Previous studies have shown that isopulegol has anxiolytic, anticonvulsant, gastro-protective and antioxidant activities in rodents, but until now there are no studies showing activity of isopulegol in animal models of nociception and inflammation. The objective of this study was to evaluate the antinociceptive effect of isopulegol and to propose possible mechanisms involved in its effects observed in mice. Groups of male and female Swiss mice (20-35\u00a0g, n\u00a0=\u00a05-8) were used in this test under the authorization of Ethics Committee on Animal Experimentation (CEEA/UFPI N\u00b0 82/2014). In order to evaluate the antinociceptive activity of isopulegol, nociception was induced using formalin test, capsaicin and glutamate in hind paw licking model, followed by the investigation of the involvement of opioid mechanisms, K\u00a0+\u00a0ATP channels, muscarinic, L arginine-nitric oxide and cGMP. The oral administration of isopulegol showed antinociceptive effect in both phases of the formalin test at doses from 0.78 to 25\u00a0mg/kg (first phase) and 1.56-25\u00a0mg/kg (second phase) and also produced significant results before capsaicin test at doses from 1.56 to 12.5\u00a0mg/kg and glutamate test at doses from 3.12 to 6.25\u00a0mg/kg with a dose-dependent effect. The antinociception activity of isopulegol was inhibited in the presence of naloxone (2\u00a0mg / kg, ip), glibenclamide (3\u00a0mg/kg, ip), atropine (1\u00a0mg/kg, ip), l-arginine (600\u00a0mg/kg, ip) and methylene blue (20\u00a0mg/kg, ip). The results suggested that acute antinociceptive action of opioid isopulegol seems to be related to the K\u00a0+\u00a0ATP channels system, through the involvement of muscarinic receptors, inhibiting nitric oxide and cGMP."], "CopyrightInformation": "Copyright \u00a9 2018. Published by Elsevier B.V."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Plants Research Center, Federal University of Piau\u00ed, Teresina, PI, Brazil."}], "LastName": "Andrade Pr\u00f3spero", "ForeName": "Deyna Franc\u00e9lia", "Initials": "DF"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Plants Research Center, Federal University of Piau\u00ed, Teresina, PI, Brazil."}], "LastName": "Reis Filho", "ForeName": "Antonio Carlos", "Initials": "AC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Plants Research Center, Federal University of Piau\u00ed, Teresina, PI, Brazil."}], "LastName": "Piauilino", "ForeName": "Celyane Alves", "Initials": "CA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Plants Research Center, Federal University of Piau\u00ed, Teresina, PI, Brazil."}], "LastName": "Lopes", "ForeName": "Everton Moraes", "Initials": "EM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences, Federal University of Para\u00edba, Jo\u00e3o Pessoa, PB, Brazil."}], "LastName": "de Sousa", "ForeName": "Dami\u00e3o Pergentino", "Initials": "DP"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Plants Research Center, Federal University of Piau\u00ed, Teresina, PI, Brazil. Electronic address: ferecal@ufpi.edu.br."}], "LastName": "de Castro Almeida", "ForeName": "Fernanda Regina", "Initials": "FR"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Ireland", "MedlineTA": "Chem Biol Interact", "NlmUniqueID": "0227276", "ISSNLinking": "0009-2797"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Analgesics"}, {"RegistryNumber": "0", "NameOfSubstance": "Cyclohexane Monoterpenes"}, {"RegistryNumber": "0", "NameOfSubstance": "Receptors, Muscarinic"}, {"RegistryNumber": "0", "NameOfSubstance": "Receptors, Opioid"}, {"RegistryNumber": "0", "NameOfSubstance": "Terpenes"}, {"RegistryNumber": "1HG84L3525", "NameOfSubstance": "Formaldehyde"}, {"RegistryNumber": "31C4KY9ESH", "NameOfSubstance": "Nitric Oxide"}, {"RegistryNumber": "3KX376GY7L", "NameOfSubstance": "Glutamic Acid"}, {"RegistryNumber": "3TH92O3BXN", "NameOfSubstance": "isopulegol"}, {"RegistryNumber": "94ZLA3W45F", "NameOfSubstance": "Arginine"}, {"RegistryNumber": "H2D2X058MU", "NameOfSubstance": "Cyclic GMP"}, {"RegistryNumber": "S07O44R1ZM", "NameOfSubstance": "Capsaicin"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Acute Disease"}, {"QualifierName": [], "DescriptorName": "Administration, Oral"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Analgesics"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["metabolism"], "DescriptorName": "Arginine"}, {"QualifierName": ["drug effects"], "DescriptorName": "Behavior, Animal"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Capsaicin"}, {"QualifierName": ["metabolism"], "DescriptorName": "Cyclic GMP"}, {"QualifierName": [], "DescriptorName": "Cyclohexane Monoterpenes"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Formaldehyde"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Glutamic Acid"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": ["metabolism", "therapeutic use"], "DescriptorName": "Nitric Oxide"}, {"QualifierName": ["chemically induced", "drug therapy"], "DescriptorName": "Pain"}, {"QualifierName": ["metabolism"], "DescriptorName": "Receptors, Muscarinic"}, {"QualifierName": ["metabolism"], "DescriptorName": "Receptors, Opioid"}, {"QualifierName": ["drug effects"], "DescriptorName": "Signal Transduction"}, {"QualifierName": ["chemistry", "pharmacology", "therapeutic use"], "DescriptorName": "Terpenes"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2018", "Month": "3", "Day": "14"}, {"Year": "2018", "Month": "7", "Day": "13"}, {"Year": "2018", "Month": "7", "Day": "23"}, {"Year": "2018", "Month": "7", "Day": "28", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "9", "Day": "19", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "7", "Day": "28", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["30053451", "10.1016/j.cbi.2018.07.019", "S0009-2797(18)30352-1"]}}]}